Inspire Medical Systems Reports Q3 Earnings Beat on EPS and Revenue
Inspire Medical Systems (NYSE: INSP) reported third-quarter financial results that exceeded analyst expectations for both earnings per share and revenue. The company posted a Non-GAAP EPS of $0.14, surpassing estimates by $0.05, while total revenue reached $206.7 million, beating consensus by approximately $2.39 million. Despite the beat, revenue saw a year-over-year decline of 7.9%. However, gross margin improved slightly by 20 basis points to 86.0%, driven largely by an improved sales mix favoring the Inspire V system. The results highlight the company's ability to maintain profitability and manage margins amidst shifting product demand.
Tickers: $INSP
Topics: earnings beat financial results gross margin revenue growth